pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
131
view
list
cards
Marketed
sacrosidase
Sucraid (sacrosidase)
Congenital Sucrase-Isomaltase Deficiency (CSID)
QOL Medical LLC
Marketed
safinamide mesylate
Safinamide Mesylate
Parkinson's Disease
Zenara Pharma Pvt Ltd
Phase 3
safusidenib
safusidenib [INN]
Malignant Glioma
$NUVB
Nuvation Bio Inc.
Phase 3
← prev
page 254 of 271
next →
Pain
89
Neurology
1
salanersen
salanersen
Spinal Muscular Atrophy (SMA)
$BIIB
BIOGEN INC.
Marketed
salmeterol xinafoate
Serevent Diskus (salmeterol xinafoate)
Asthma
GlaxoSmithKline LLC
Preclinical
salsalate
salsalate
Polycystic Kidney Disease
J and D Pharmaceuticals LLC
Phase 2
samelisant
samelisant [INN]
Narcolepsy
Suven Life Sciences Ltd
Phase 2
sapablursen sodium
sapablursen sodium
Polycythemia Vera
Ono Pharmaceutical Co Ltd
Phase 2
saracatinib difumarate
saracatinib difumarate
Idiopathic Pulmonary Fibrosis
$AZN
ASTRAZENECA PLC
Marketed
sarecycline hydrochloride
Seysara (sarecycline hydrochloride)
Acne Vulgaris
Almirall SA
Phase 3
sargramostim
Leukine (sargramostim)
Metastatic Melanoma
Partner Therapeutics Inc
Phase 2
sarilumab
Kevzara (sarilumab)
Systemic-Onset Juvenile Idiopathic Arthritis (Still Disease)
$REGN
REGENERON PHARMACEUTICALS, INC.
Phase 3
saroglitazar magnesium
Lipaglyn (saroglitazar magnesium)
Primary Biliary Cholangitis (Primary Biliary Cirrhosis)
Zydus Therapeutics Inc
Phase 3
satralizumab
Enspryng (satralizumab-mwge)
Demyelinating Diseases
F. Hoffmann-La Roche Ltd
Phase 2
satricabtagene autoleucel
satricabtagene autoleucel
Adenocarcinoma Of The Gastroesophageal Junction
CARsgen Therapeutics Holdings Ltd
Phase 2
savolitinib
savolitinib
Non-Small Cell Lung Cancer
$AZN
ASTRAZENECA PLC
Marketed
saxagliptin
Saxagliptin
Type 2 Diabetes
Glenmark Pharmaceuticals Ltd
Marketed
scorpion [centruroides] (polyvalent) immunoglobulin F(ab’) 2 antivenom [equine]
Anascorp
Poisoning
Rare Disease Therapeutics Inc
Marketed
sebelipase alfa
Kanuma (sebelipase alfa)
Lysosomal Acid Lipase Deficiency
Alexion Pharmaceuticals Inc
Marketed
sebetralstat
Ekterly (sebetralstat [INN])
Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-IN…
$KALV
KalVista Pharmaceuticals, Inc.
Marketed
secnidazole
Solosec (secnidazole)
Bacterial Vaginosis
$EVFM
Evofem Biosciences, Inc.
Marketed
secukinumab
Cosentyx (secukinumab)
Hidradenitis Suppurativa
$NVS
NOVARTIS AG
Phase 2
secutrelvir
secutrelvir [INN]
Coronavirus Disease 2019 (COVID-19)
$SGIOF
SHIONOGI & CO LTD
Phase 3
sefaxersen sodium
sefaxersen sodium
IgA Nephropathy (Berger's Disease)
F. Hoffmann-La Roche Ltd
Phase 3
selatogrel
selatogrel [INN]
Myocardial Infarction
Idorsia Pharmaceutical Ltd
Phase 2
selcodebart
selcodebart [INN]
Anemia
$IRON
Disc Medicine, Inc.
Marketed
selegiline ER
Emsam (selegiline)
Major Depressive Disorder
Mylan Specialty LP
Marketed
selegiline hydrochloride
Selegiline Hydrochloride
Parkinson's Disease
i3 Pharmaceuticals LLC
Marketed
selegiline hydrochloride ODT
Zelapar (selegiline hydrochloride)
Parkinson's Disease
$BHC
Bausch Health Companies Inc.
Phase 3
selenium sulfide
Selenium Sulfide (selenium sulfide [USP])
Meibomian Blepharitis
Azura Ophthalmics Pty Ltd
